Healio

New KDIGO blood pressure targets affect more than 10% of patients with CKD

Please provide your email address to receive an email when new articles are posted on . The expanded indication for BP-lowering treatment by the 2021 Kidney Disease: Improving Global Outcomes ...
Healio

KDIGO guideline adherence may help reduce moderate or severe AKI after surgery

Please provide your email address to receive an email when new articles are posted on . Patients who received a preventive care strategy had significantly lower odds for moderate or severe AKI.
Seeking Alpha

Nefecon Included in the Updated KDIGO Clinical Practice Guideline, Strengthening Asahi Kasei’s Position in IgA Nephropathy Treatment

The final 2025 KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function TARPEYO is a key product in Asahi Kasei’s ...
Nasdaq

New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, commented today on the 2024 Clinical Practice Guideline for the Evaluation and Management of ...
Business Wire

Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care

LONDON--(BUSINESS WIRE)--Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration ...
Medical Xpress

Improved outcomes seen with lower 2021 KDIGO BP target

The newly lowered Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure (BP) target systolic BP (SBP) of <120 mm Hg is associated with improved outcomes compared with the 2012 KDIGO BP ...
Business Wire

CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the ...
MedPage Today

Guiding Practice Through the Latest KDIGO Guidelines on ADPKD

The Kidney Disease: Improving Global Outcomes (KDIGO) group has released its 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney ...
Renal & Urology News

KDIGO Updates Blood Pressure Guideline for Nondialysis CKD

BP Meds May Not Eliminate CVD Risk The new KDIGO guideline recommendation to target a systolic blood pressure of less than 120 mm Hg in many patients with nondialysis CKD is lower than the target ...
Seeking Alpha

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO ...
KTLA

New KDOQI Commentary of 2021 KDIGO Clinical Practice Guideline for Glomerular Diseases Published

NEW YORK, June 21, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) and its Kidney Disease Outcomes Quality Initiative (KDOQI) are pleased to announce the publication of the KDOQI US ...